[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 4 of about 4
1. Rassu PC, Cassinelli G, Ronzitti F, Bronzino P, Stanizzi T, Casaccia M: [Primary adenocarcinoma of the appendix. Case report and review of the literature]. Minerva Chir; 2002 Oct;57(5):695-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary adenocarcinoma of the appendix. Case report and review of the literature].
  • [Transliterated title] Adenocarcinoma primitivo dell'appendice. Descrizione di un caso clinico e revisione della letteratura.
  • A rare case of primary adenocarcinoma of the vermiform appendix (less than 250 cases described in the literature) in a 36 year-old female patient presenting signs and symptoms of an acute appendicitis is reported.
  • Adeno-carcinoma of the vermiform appendix is a rare neoplasm of the gastrointestinal tract with an incidence of about 0,01-0,2%.
  • Usually the diagnosis of adenocarcinoma of the vermiform appendix is difficult because symptoms and signs are not pathognomonic.
  • In the case described, the diagnosis was intra and postoperative and confirmed by the pathological examination of the surgical specimens.
  • At laparotomy, performed under suspicion of an acute appendicitis, disseminated disease was discovered, characterized by the involvement of the two ovaries, the left colon, the cecum, the vermiform appendix, with a peritoneal carcinosis and a hydroureteronephrosis.
  • [MeSH-major] Adenocarcinoma / diagnosis. Appendiceal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Appendectomy. Appendicitis / diagnosis. Cecal Neoplasms / drug therapy. Cecal Neoplasms / secondary. Cecal Neoplasms / surgery. Chemotherapy, Adjuvant. Colonic Neoplasms / drug therapy. Colonic Neoplasms / secondary. Colonic Neoplasms / surgery. Diagnosis, Differential. Female. Fluorouracil / administration & dosage. Humans. Hydronephrosis / etiology. Laparotomy. Organoplatinum Compounds / administration & dosage. Ovarian Neoplasms / drug therapy. Ovarian Neoplasms / secondary. Ovarian Neoplasms / surgery. Peritoneal Neoplasms / drug therapy. Peritoneal Neoplasms / secondary. Peritoneal Neoplasms / surgery

  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12370673.001).
  • [ISSN] 0026-4733
  • [Journal-full-title] Minerva chirurgica
  • [ISO-abbreviation] Minerva Chir
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; U3P01618RT / Fluorouracil
  • [Number-of-references] 13
  •  go-up   go-down


2. Schwartz GK, Bertino J, Kemeny N, Saltz L, Kelsen DK, Tong W, Welch M, Endres S, Dimery I: Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer. Anticancer Drugs; 2004 Mar;15(3):219-27
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer.
  • Our objective was to determine the maximum tolerated dose (MTD) of sequential raltitrexed (Tomudex) and 5-fluorouracil (5-FU) by bolus administration every 3 weeks in patients with advanced colorectal cancer (aCRC) and appendiceal adenocarcinoma.
  • We conclude that raltitrexed can be combined with bolus 5-FU, at raltitrexed doses that are higher than the recommended single-agent dose of 3.0 mg/m, with manageable toxicity.
  • [MeSH-major] Colorectal Neoplasms / drug therapy. Fluorouracil / administration & dosage. Quinazolines / administration & dosage. Thiophenes / administration & dosage
  • [MeSH-minor] Adult. Aged. Confidence Intervals. Drug Administration Schedule. Female. Humans. Male. Middle Aged. Odds Ratio. Survival Analysis

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15014354.001).
  • [ISSN] 0959-4973
  • [Journal-full-title] Anti-cancer drugs
  • [ISO-abbreviation] Anticancer Drugs
  • [Language] eng
  • [Publication-type] Clinical Trial; Clinical Trial, Phase I; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Quinazolines; 0 / Thiophenes; FCB9EGG971 / raltitrexed; U3P01618RT / Fluorouracil
  •  go-up   go-down


3. Topkan E, Polat Y, Karaoglu A: Primary mucinous adenocarcinoma of appendix treated with chemotherapy and radiotherapy: a case report. Tumori; 2008 Jul-Aug;94(4):596-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary mucinous adenocarcinoma of appendix treated with chemotherapy and radiotherapy: a case report.
  • A rare case of primary appendiceal mucinous adenocarcinoma is reported.
  • An appendectomy was performed resulting in a histological diagnosis of grade 2 mucinous adenocarcinoma of the appendix.
  • [MeSH-major] Adenocarcinoma, Mucinous / drug therapy. Adenocarcinoma, Mucinous / radiotherapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Appendiceal Neoplasms / drug therapy. Appendiceal Neoplasms / radiotherapy. Colectomy
  • [MeSH-minor] Capecitabine. Chemotherapy, Adjuvant. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Drug Administration Schedule. Fluorouracil / administration & dosage. Fluorouracil / analogs & derivatives. Humans. Lymph Node Excision. Male. Middle Aged. Neoplasm Staging. Organoplatinum Compounds / administration & dosage. Radiotherapy, Adjuvant. Treatment Outcome

  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18822701.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  •  go-up   go-down


Advertisement
4. Gehrig PA, Boggess JF, Ollila DW, Groben PA, Van Le L: Appendix cancer mimicking ovarian cancer. Int J Gynecol Cancer; 2002 Nov-Dec;12(6):768-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Appendix cancer mimicking ovarian cancer.
  • Appendiceal adenocarcinoma is a rare malignancy for which there is no characteristic clinical presentation.
  • We describe five women who presented with signs and symptoms characteristic of advanced ovarian cancer but whose final diagnosis was stage IV appendiceal cancer.
  • Between 1998 and 1999, five women treated for presumed ovarian cancer were identified as having primary appendiceal cancer.
  • Four had postoperative chemotherapy, the most common agent used was 5-flourouracil.
  • Primary adenocarcinoma of the appendix is rare; therefore, the clinical utility of radical tumor debulking and chemotherapy is not well described.
  • Although this disease process is uncommon, it should be entertained by gynecologic oncologists in the differential diagnosis of an intra-abdominal mass and ascites.
  • The ability to make the correct diagnosis and differentiate between an ovarian and appendiceal primary is critical as the treatment modalities vary.
  • [MeSH-major] Adenocarcinoma / mortality. Appendiceal Neoplasms / mortality. Ovarian Neoplasms / mortality
  • [MeSH-minor] Adult. CA-125 Antigen / blood. Chemotherapy, Adjuvant. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Keratins. Medical Records. Middle Aged. North Carolina / epidemiology. Palliative Care. Retrospective Studies. Survival Analysis. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12445258.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CA-125 Antigen; 68238-35-7 / Keratins
  •  go-up   go-down






Advertisement